Alpha Teknova (NASDAQ:TKNO) Stock Price Up 1.3%

Alpha Teknova, Inc. (NASDAQ:TKNO)’s stock price was up 1.3% during mid-day trading on Thursday . The stock traded as high as $1.95 and last traded at $1.94. Approximately 10,380 shares were traded during mid-day trading, a decline of 27% from the average daily volume of 14,277 shares. The stock had previously closed at $1.91.

Analysts Set New Price Targets

Separately, BTIG Research lowered Alpha Teknova from a “buy” rating to a “neutral” rating in a research note on Tuesday, March 12th.

Alpha Teknova Price Performance

The firm has a market capitalization of $78.99 million, a P/E ratio of -1.67 and a beta of 0.39. The business’s 50-day simple moving average is $2.55 and its 200 day simple moving average is $2.74. The company has a quick ratio of 3.84, a current ratio of 5.14 and a debt-to-equity ratio of 0.15.

Alpha Teknova (NASDAQ:TKNO) last released its earnings results on Monday, March 11th. The company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.01. Alpha Teknova had a negative net margin of 100.26% and a negative return on equity of 38.12%. The company had revenue of $7.87 million for the quarter, compared to analyst estimates of $8.20 million. Sell-side analysts forecast that Alpha Teknova, Inc. will post -0.66 earnings per share for the current year.

Institutional Investors Weigh In On Alpha Teknova

Institutional investors have recently bought and sold shares of the stock. Fielder Capital Group LLC bought a new position in shares of Alpha Teknova in the fourth quarter worth approximately $156,000. Conestoga Capital Advisors LLC grew its holdings in Alpha Teknova by 4.1% in the 4th quarter. Conestoga Capital Advisors LLC now owns 247,529 shares of the company’s stock worth $923,000 after acquiring an additional 9,800 shares during the last quarter. Finally, Platinum Investment Management Ltd. increased its position in shares of Alpha Teknova by 169.9% in the third quarter. Platinum Investment Management Ltd. now owns 834,529 shares of the company’s stock valued at $2,328,000 after acquiring an additional 525,351 shares during the period. 13.81% of the stock is currently owned by hedge funds and other institutional investors.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.